Log in or Sign up for Free to view tailored content for your specialty!
Optometry News
‘Change agents’ selected for AOA-CooperVision myopia initiative
NASHVILLE, Tenn. — The American Optometric Association and CooperVision announced the 60 inaugural “change agents” who will lead the Myopia Collective, an initiative that advocates for comprehensive treatment for myopia.
FDA grants de novo classification to Fysx ocular pressure adjusting pump
The FDA granted de novo classification to the Fysx ocular pressure adjusting pump for patients with normal-tension glaucoma or open-angle glaucoma with IOP of 21 mm Hg or less, according to a press release from Balance Ophthalmics.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Optometrists should ‘consider myopia as a disease’ in children
NASHVILLE, Tenn. — Treatment should be offered to all children with myopia, even in its early stages, according to a corporate executive at Optometry’s Meeting.
Apellis seeks reexamination after negative opinion for pegcetacoplan in Europe
The Committee for Medicinal Products for Human Use of the European Medicines Agency issued a negative opinion on the marketing authorization application for pegcetacoplan for the treatment of geographic atrophy.
VIDEO: Three retinal therapies from Kodiak entering phase 3 studies
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Victor Perlroth, MD, CEO of Kodiak Sciences, provides an overview of the company’s ongoing retinal therapy programs.
VIDEO: Report shows patients expect their doctors to initiate contact lens discussion
NASHVILLE, Tenn. — Many patients are interested in contact lenses but wait for their provider to bring them up, according to a clinician speaking at Optometry’s Meeting about a recent Contact Lens Institute report.
VIDEO: Clinical signs, symptoms can help diagnose keratoconus in absence of technology
NASHVILLE, Tenn. — Listening to patients’ complaints and noting refractive or keratometry changes can enable clinicians to identify keratoconus even in the absence of a topographer, a speaker said at Optometry’s Meeting.
VIDEO: Outlook Therapeutics enrolling patients in trial of ONS-5010
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Russ Trenary, president and CEO of Outlook Therapeutics, discusses the development of ONS-5010.
Novel implants show promise in drug delivery
KIAWAH ISLAND, S.C. — Drug-eluting implants in various stages of study and approval may provide efficient, sustained drug delivery, overcoming barriers to penetration, according to a speaker at Kiawah Eye.
VIDEO: Regenxbio offers updates on ABBV-RGX-314 programs
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Steve Pakola, MD, chief medical officer of Regenxbio, shares updates on the company’s retina programs.
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read